The Research of French PaRole OncO : A Peer Supported Program for Cancer Patients

Not Applicable

Not yet recruiting

• Conditions: Cancer

• Registration Number: NCT06817655
• Lead Sponsor: Hospices Civils de Lyon

Brief Summary

Peer support is a valuable mode of accompaniment between individuals who are facing or have faced similar challenging life experiences. In this context, a patient advisor (PA) shares their experiential knowledge, derived from living with a disease, to offer emotional, experiential, and informational support to other patients. This PA intervention represents an innovative form of support for oncology patients, potentially addressing their needs more comprehensively throughout the care pathway by integrating psychosocial dimensions into the support approach.

The present pilot study aims to investigate the implementation and effectiveness of the peer-to-peer support program "PaRole OncO France" in the oncology setting. The study will focus on:

1. Evaluating clinical and psychosocial parameters

2. Utilizing an in-depth multiple case study approach This research seeks to provide insights into how peer support can enhance the overall care experience for oncology patients, potentially leading to improved patient outcomes and a more holistic approach to cancer care.

Detailed Description

Peer support is a valuable mode of accompaniment between individuals who are facing or have faced similar challenging life experiences. In this context, a patient advisor (PA) shares their experiential knowledge, derived from living with a disease, to offer emotional, experiential, and informational support to other patients. This PA intervention represents an innovative form of support for oncology patients, potentially addressing their needs more comprehensively throughout the care pathway by integrating psychosocial dimensions into the support approach.

The present pilot study aims to investigate the implementation and effectiveness of the peer-to-peer support program "PaRole OncO France" in the oncology setting. The study will focus on:

1. Evaluating clinical and psychosocial parameters

2. Utilizing an in-depth multiple case study approach This research seeks to provide insights into how peer support can enhance the overall care experience for oncology patients, potentially leading to improved patient outcomes and a more holistic approach to cancer care.

Study Timeline

• Status Verified: 2025-01
• Study First Submitted: 2025-01-29
• Study First Submitted QC: 2025-02-05
• Last Update Submitted: 2025-02-05
• Study First Posted: 2025-02-10
• Last Update Posted: 2025-02-10
• Study Start: 2025-03-15
• Primary Completion: 2027-06-15
• Study Completion: 2027-06-15

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 720

Inclusion Criteria

• Patient participants :

  • Patients with newly diagnosed or recurrent cancer (urological, digestive, mammary, pulmonary, ORL, peritoneal carcinosis, melanoma, oncohaematology)
  • French-speaking patients

• Patients adivsors :

  • Patient advisors will be past cancer patients not currently undergoing treatment for their cancer, and considered without evidence of disease
  • French-speaking patients

Exclusion Criteria

• Patients participants :

  • Not followed in one of the participating units
  • Persons deprived of their liberty by judicial or administrative decision
  • Persons not affiliated to a social security scheme or beneficiaries of a similar scheme

• Patient advisors :

  • Recurrence of the disease
  • Currently undergoing treatment for active cancer

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Feasibility of implementation of the Peer Support Program in Oncology	30 months	Acceptability of PH intervention by patients, professionals, and PAs Number of PHs integrated per unit Maintenance of PH activity during the study period in each unit Primary outcome measure is multidimensional by design, as the evaluation of a peer support program requires simultaneous analysis of complementary aspects (acceptability, feasibility, fidelity). These elements are inherently interconnected within our methodological framework.

Secondary Outcome Measures

Name	Time	Method
Evolution of stress levels	6 months	Hospital Anxiety and Depression Scale ((Min : 0; Max : 42).Higher scores indicate greater levels of anxiety and depression.
Evolution of quality of life	1 month, 6 month	EORTC QLQ-C30 questionnaire(Min : 0 ; Max : 100).Higher scores indicate better health status and quality of life.
Evolution of patient-perceived care experience	6 months	Picker Patient Experience questionnaire(Min : 0 ; Max : 100). Higher scores indicate a better patient experience and greater satisfaction.
Patient empowerment	6 month	CASE-cancer questionnaire(Min :0 ; Max : 100). Higher scores indicate greater self-efficacy in managing cancer.
Evolution of relationship between accompanied patients and healthcare professionals	Baseline;1 month and 6 month after intervention	CADICEE questionnaire(Min :0 ; Max : 100). Higher scores indicate a better perception of patient-healthcare partnership
Evolution of quality of life of patient advisors	Baseline, 1month, 6 month	SF-12 questionnaire(Min :0 ; Max : 100)Higher scores indicate better health-related quality of life.

Trial Locations

Locations (1)

Hospices Civils de Lyon; 🇫🇷 Lyon, France